Rheumatoid Arthritis（RA）

HKB's NHP Rheumatoid Arthritis Models offer pharmaceutical companies advanced translational platforms for developing novel RA therapeutics. Our non-human primate models replicate key features of rheumatoid arthritis, including synovial inflammation, pannus formation, cartilage destruction, and bone erosion. These models support evaluation of DMARDs, biologics, JAK inhibitors, and novel immunomodulatory approaches.